Vedanta Share Price Recovers from Low; Demerger Approved by Shareholders and Creditors

Vedanta Ltd has secured strong approval for its demerger proposal, with 99.99% of shareholders, 99.59% of secured creditors, and 99.95% of unsecured creditors voting in favour of the split. The company, in its stock exchange filing, confirmed the approval and outlined the next steps in the demerger process.

Vedanta’s share price recovers from the day’s low to trade near the day’s high. As of 10:58 AM on February 20, 2025, the stock is trading 0.68% higher.

Key Details of the Vedanta Demerger Scheme

Under the demerger plan, each Vedanta shareholder will receive 1 additional share in each of the 4 newly created entities upon the completion of the process. The restructuring aims to enhance focus, operational efficiency, and investor interest in each of the individual businesses.

The 5 Newly Formed Companies

Following the demerger, Vedanta Ltd will be divided into 5 independent, sector-specific companies:

  1. Vedanta Aluminium – One of the world’s largest aluminium producers.
  2. Vedanta Oil & Gas – India’s largest private-sector crude oil producer.
  3. Vedanta Power – A key player in India’s power generation sector.
  4. Vedanta Iron & Steel – Managing a scalable ferrous portfolio.
  5. Vedanta Limited – Retaining its interests in Hindustan Zinc, the world’s second-largest integrated zinc producer and third-largest silver producer.

Additionally, Vedanta Ltd will serve as an incubator for emerging businesses, including technology ventures.

Strategic Rationale Behind the Demerger

Vedanta’s leadership has stated that the demerger will help streamline operations and improve the efficient utilisation of assets. By separating business verticals, each entity will be better positioned to:

  • Focus on core competencies.
  • Optimise operational efficiencies.
  • Attract targeted investments and strategic partnerships.
  • Secure independent funding through debt or equity markets.

Market Implications and Investor Perspective

The restructuring is expected to unlock value for shareholders by allowing them to invest selectively in businesses that align with their financial strategies and risk appetites. Different entities will have the flexibility to pursue sector-specific growth opportunities without being constrained by the broader conglomerate structure.

The move is also anticipated to enhance capital market access, making it easier for each company to secure funding tailored to its industry needs.

Regulatory Approvals and Next Steps

While the demerger has received shareholder and creditor approval, it remains subject to regulatory clearances, including those from the National Company Law Tribunal (NCLT) and other statutory authorities. The company will continue to navigate the required approvals before finalising the separation process.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Gulshan Polyols Secures ₹124 Crore Ethanol Supply Order; Share Price Jumps 8%

Gulshan Polyols Limited (GPL) has been awarded a significant allocation for ethanol supply under the Ethanol Blended Petrol Programme (EBPP) for the Ethanol Supply Year (ESY) 2024-25. The company participated in a tender process floated by major Oil Marketing Companies (OMCs) and secured an order to supply 21,220 kilolitres of ethanol, valued at ₹1,24,13,70,000.

This development comes as part of the Indian government’s initiative to boost ethanol blending in petrol, reducing reliance on fossil fuels and promoting renewable energy sources. The ethanol allocation was awarded by Bharat Petroleum Corporation Limited (BPCL), Indian Oil Corporation Limited (IOCL), Hindustan Petroleum Corporation Limited (HPCL), and Mangalore Refinery and Petrochemicals Limited (MRPL). The supply execution will take place throughout ESY 2024-25.

Broader Allocation Details

Beyond this specific allocation cycle (C3), Gulshan Polyols has secured ethanol supply orders across multiple cycles for ESY 2024-25, amounting to a total allocation of 1,82,242 kilolitres. This cumulative allocation reinforces the company’s strong presence in the ethanol supply sector.

The broader allocation includes a substantial order in Cycle 1, where the company secured 1,42,222 kilolitres of ethanol with an estimated value of ₹9,93,94,31,620. In Cycle 2, GPL was awarded 18,800 kilolitres, valued at ₹1,35,09,68,000, and in Cycle 3, the company received 21,220 kilolitres worth ₹1,24,13,70,000. In total, the company has secured ethanol supply contracts worth ₹12,53,17,69,620 for ESY 2024-25.

This large-scale allocation underscores GPL’s strong foothold in the ethanol market, aligning with India’s target of achieving 20% ethanol blending in petrol by 2025.

Understanding the Ethanol Blended Petrol Programme (EBPP)

The EBPP is a government initiative aimed at reducing dependency on fossil fuels by blending ethanol with petrol. This transition not only lowers carbon emissions but also enhances energy security and supports the agrarian economy by utilising surplus sugarcane and other bio-based sources. Ethanol blending has gained significant momentum, with the government providing incentives to ethanol producers and oil marketing companies to achieve higher blending targets.

Impact on Gulshan Polyols and Market Reaction

The ethanol supply allocation positions GPL as a key player in the government’s clean energy push. The company’s substantial order book for ESY 2024-25 reflects its ability to capitalise on the rising ethanol demand. Market sentiment around this development has been positive, leading to an 8% surge in the company’s share price following the announcement.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Avantel Secures ₹43.25 Crore Order from NewSpace India for Xponder Devices

Avantel Limited, a technology-driven company, has announced that it has secured a significant purchase order worth ₹43.25 crore (including taxes) from NewSpace India Limited. The company disclosed this development in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The share price of Avantel on February 20, 2025, opened at ₹114.89, higher by 7.40%. 

Details of the Order

The purchase order involves the supply, installation, and commissioning of Xponder devices, signifying Avantel’s continued role in advanced communication and satellite-related solutions. The contract has been awarded by NewSpace India Limited, a key entity in India’s space sector, and falls under the manufacturing category. This is a domestic contract, and the execution timeline has been set for August 2025. The deal underscores Avantel’s growing presence in high-tech manufacturing, further strengthening its footprint in the industry.

Strategic Importance of the Deal

This contract strengthens Avantel’s position in the domestic technology sector, highlighting its role in providing advanced communication and satellite solutions. The collaboration with NewSpace India Limited—a key player in India’s space sector—further underscores Avantel’s capabilities in high-tech manufacturing.

Q3FY25 Financial Performance 

The company reported a 23.04% rise in consolidated net profit, reaching ₹20.08 crore in Q3FY25, up from ₹16.32 crore in the corresponding quarter of the previous year.

Revenue from operations for the quarter stood at ₹70.68 crore, reflecting a 19.14% year-on-year (Y-o-Y) increase compared to ₹59.33 crore in December 2023.

No Related Party Transactions

Avantel has clarified that there is no involvement of promoters, promoter groups, or related parties in this transaction, ensuring transparency in its dealings

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

HFCL Secures Agreement with BSNL for BharatNet Phase III Implementation in Punjab

HFCL Limited has officially signed an agreement with Bharat Sanchar Nigam Limited (BSNL) to implement BharatNet Phase III in the Punjab Telecom Circle. This development follows HFCL’s earlier receipt of an Advance Work Order (AWO) from BSNL, valued at approximately ₹2,501.30 crore.

The share price of HFCL on February 20, 2025, opened at ₹88.53, down by 0.30%.

Strengthening Digital Connectivity in Punjab

As part of this agreement, HFCL will serve as the Project Implementation Agency (PIA) for BharatNet Phase III, an initiative aimed at expanding broadband connectivity to rural and underserved regions of Punjab. BharatNet is a flagship government programme designed to enhance digital access across India, facilitating the last-mile fibre-optic connectivity necessary to bridge the digital divide.

HFCL Becomes the First to Sign Under BharatNet Phase III

HFCL’s agreement with BSNL marks a significant milestone, as the company becomes the first to formalise such a contract under BharatNet Phase III. This underscores its role as a key player in India’s telecommunications infrastructure, furthering its commitment to strengthening digital networks nationwide.

Next Steps: Project Implementation to Begin

With the agreement in place, HFCL is set to commence project implementation immediately. The initiative will involve the deployment of high-speed fibre-optic networks, supporting the Indian government’s vision of widespread digital inclusion.

Management Ambition to Reach ₹10,000 Crore Revenue

Last week, HFCL’s Managing Director, Mahendra Nahata, stated that the company is focusing on expanding overseas sales and increasing defence supply uptake as part of its ambition to become a ₹10,000-crore revenue enterprise.

“We are increasing our presence by appointing our own employees, distributors, and dealers in key global markets. Our goal is to achieve a substantial rise in export revenue from our optic fibre segment, with a significant portion of revenue coming from international markets in the coming years. Additionally, we aim for a considerable share of our telecom segment revenue to be export-driven,” Nahata had said.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Indiabulls Enterprises Reports Over ₹1,000 Crore Sales in Indiabulls Estate & Club-I

Indiabulls Enterprises has announced the sale of 195 units in its premium residential project, Indiabulls Estate & Club-I, surpassing ₹1,000 crore in sales within just 30 days of launch. The project, unveiled on January 14, 2025, has garnered significant interest from homebuyers, reflecting a growing demand for high-end housing in Gurugram.

Prime Location and Connectivity

Spread across 24 acres, Indiabulls Estate & Club-I is strategically located on the Dwarka Expressway, Gurugram, offering seamless connectivity to key business districts in Gurugram and Delhi-NCR. This advantageous location enhances its appeal among professionals and investors looking for premium living spaces with easy access to commercial hubs.

A Blend of Green Living and Modern Amenities

The project is designed with a focus on sustainable and luxury living, incorporating green spaces and state-of-the-art amenities. With an emphasis on eco-friendly infrastructure, high-end recreational facilities, and a premium lifestyle, Indiabulls Estate & Club-I positions itself as a notable addition to Gurugram’s evolving luxury housing landscape.

Share Price Performance

In the last week, the share price of Indiabulls Enterprises has declined by 10.92%, while over the past month, it has fallen by 15.22%.

About Indiabulls Enterprises 

Indiabulls Enterprises is engaged in construction equipment rental and leasing services, offering a comprehensive range of machinery and turnkey solutions to Engineering Procurement & Construction (EPC) companies. The company provides heavy-duty tower cranes, passenger hoists, piling rigs, excavators, dozers, motor graders, wheel loaders, mobile boom placers, and steel stir-up machines, among other advanced construction and infrastructure equipment.

The equipment fleet consists of global brands known for superior productivity and efficiency, catering to the construction, infrastructure, manufacturing, and mineral handling industries. With offices in Mumbai, Gurgaon, Kolkata, Hyderabad, and Bangalore, along with rental yards at key locations across India, the company ensures seamless service delivery and enhanced operational efficiency.

Operating in a highly fragmented and diverse equipment rental market, Dhani Services has built competitive advantages through its extensive resources and professional execution. The company’s sustainable business model and broad fleet range enable it to serve multiple industries with different trade cycles, reinforcing its reputation as a reliable partner in the construction and infrastructure sectors.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

India Glycols Share Price in Focus; Secures ₹1,264.20 Crore Ethanol Supply Allocation for EBPP

India Glycols Limited has announced that it has received an allocation for the supply of 18.06 crore litres of ethanol under the Ethanol Blended Petrol Programme (EBPP) for the Ethanol Supply Year (ESY) 2024-25. The total estimated value of the allocated supply stands at ₹1,264.20 crore, reinforcing the company’s role in India’s growing ethanol-blending initiative.

The share price of India Glycols has gained 32.54% in the past 1 year and the stock is down by 13% in the last 1 month. 

Who Awarded the Allocation?

The ethanol supply allocation has been awarded by key public and private sector entities, including:

These entities collectively form the key players in India’s fuel distribution network, working towards increasing ethanol blending in petrol to reduce the country’s dependency on crude oil imports.

Breakdown of the Allocation

The ethanol allocation for ESY 2024-25 has been distributed among different entities as follows:

 

Entity Quantity (crore litres) Estimated Value (₹ crore)
Oil Marketing Companies (OMCs) (BPCL, IOCL, HPCL) 17.53 1227.1
Private Oil Companies (Reliance, Nayara Energy) 0.53 37.1
Total 18.06 1264.2

 

Ethanol Supply from Kashipur and Gorakhpur Plants

India Glycols will fulfil the ethanol supply allocation from its plants located in Kashipur and Gorakhpur. The ethanol supplied under this contract is produced using:

  • Damaged Food Grains (DFG)
  • Surplus Food Corporation of India (FCI) Rice

This aligns with the government’s initiative to use alternative feedstocks for ethanol production, reducing reliance on sugarcane-derived ethanol and ensuring sustainable fuel supply.

Contract Details and Execution Timeline

The ethanol supply contract is domestic in nature, covering the period from November 1 2024 to October 31, 2025. The contract does not involve any related party transactions, and the company’s promoters do not have any direct interest in the awarding entities.

India’s Ethanol Blending Goals

The Ethanol Blended Petrol Programme (EBPP) is part of the Indian government’s broader strategy to enhance ethanol blending in petrol, aiming for 20% ethanol blending by 2025-26. This initiative contributes to:

  • Reducing carbon emissions
  • Enhancing energy security
  • Supporting the agricultural sector through the utilisation of food grain surplus

India Glycols’ latest allocation further cements its role in this crucial national objective.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Market Correction Hits LIC Portfolio: Portfolio Value Drops by ₹84,000 Crore

The Indian stock market is undergoing a significant correction, which has had a substantial impact on the portfolio of the Life Insurance Corporation of India (LIC). According to reports, the market value of LIC’s holdings has declined by ₹84,247 crore in just the past one and a half months.

As of December 2024, LIC’s total holdings in listed companies were valued at ₹14.72 trillion, which has now fallen to ₹13.87 trillion as of February 18, 2025. This marks a 5.7% decline, reflecting the widespread market volatility. The study analysed 330 companies in which LIC held over a 1% stake during the October-December 2024 quarter. These companies collectively accounted for 66% of the total market capitalisation of all BSE-listed companies.

ITC, L&T, and SBI Drive Major Losses

A large portion of LIC’s portfolio decline can be attributed to the steep correction in shares of ITC, Larsen & Toubro (L&T), and State Bank of India (SBI). These stocks have witnessed a fall of over 10% in CY25, leading to a combined loss of:

  • ITC: ₹11,863 crore
  • L&T: ₹6,713 crore
  • SBI: ₹5,647 crore

Together, these 3 stocks accounted for 29% of LIC’s total value erosion.

Market Erosion Across Key Stocks

LIC has experienced market value erosion of ₹1,000 crore or more in 26 companies, with notable declines in:

Losses in these stocks range from ₹2,000 crore to ₹4,000 crore, highlighting the impact of the broader market correction.

NBFCs and Insurance Stocks Among Top Value Destroyers

The report also noted that non-banking financial companies (NBFCs) and insurance companies contributed significantly to the decline. These sectors were among the top value destroyers, leading to a combined portfolio erosion of ₹18,385 crore, making up 22% of the total loss.

Some Stocks Defied the Market Trend

Despite the overall downturn, some stocks in LIC’s portfolio managed to add value. Companies that saw an increase in LIC’s holding value by ₹1,000 crore to ₹3,000 crore included:

These stocks defied the broader market trend, offering some resilience to LIC’s portfolio amid the correction.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Tata Group Invests ₹500 Crore in Breach Candy Hospital Infrastructure

Tata Group, a stalwart in India’s business landscape, is set to deepen its engagement in the healthcare sector through a substantial ₹500-crore investment in Mumbai’s prestigious Breach Candy Hospital. This initiative underscores Tata’s commitment to strengthening healthcare infrastructure, modernising medical facilities, and enhancing patient care. By formalising its long-standing relationship with the hospital, Tata is poised to play a pivotal role in its future development.

Tata’s Strategic Investment in Healthcare

Tata Group, India’s largest business conglomerate, is expanding its healthcare footprint by making a substantial financial commitment to Breach Candy Hospital. This investment will establish Tata as the hospital’s largest financial backer, enabling governance influence through the addition of three representatives to the 14-member board of trustees. The funds will be allocated towards infrastructure upgrades, integration of advanced medical technology, and overall service enhancements.

Leadership Transition and Governance Impact

As part of this transition, Tata Group Chairman N Chandrasekaran will assume the role of chairman of the Breach Candy Hospital Trust, succeeding veteran banker Deepak Parekh on October 1, 2025. Parekh will continue to serve as a trustee, ensuring leadership stability. While the hospital will retain its historic name, discussions are underway to incorporate Tata’s branding, potentially rebranding it as “Breach Candy, a Tata Sons associate.”

Ratan Tata’s longstanding association with the hospital—both as a benefactor and a patient—has now evolved into a formal partnership. Through Tata Trusts, he has previously contributed financial aid for infrastructure development and medical equipment procurement. This official collaboration strengthens Tata’s role in shaping the hospital’s future direction.

Breach Candy’s Legacy and Corporate Influence

Established in 1946, Breach Candy Hospital holds historical significance, having been founded by the European Hospital Trust with financial support from pre-independence corporations such as Unilever, Forbes, and Crompton Greaves. The institution introduced India’s first MRI facility in 1998 and has treated several prominent figures, including former Prime Minister Atal Bihari Vajpayee and actor Amitabh Bachchan.

 

The hospital operates under the Breach Candy Hospital Trust, registered under the Indian Trusts Act and Section 8 of the Companies Act. It is overseen by a distinguished board of trustees, including business leaders such as Anand Mahindra, Rajashree Birla, Pallon Mistry, S Ramadorai, and Jamshyd Godrej. While Tata Group will now play a formal role in governance, independent members such as Ramadorai and Mehli will remain outside its direct influence.

The Future of Corporate Healthcare Investments

Tata’s entry into the healthcare sector aligns with a broader trend of corporate investment in medical infrastructure. The Adani Group’s plan to establish a 1,000-bed hospital and medical college in Kandivali highlights the increasing corporate interest in Mumbai’s healthcare landscape. Alongside industry players like Reliance, Hinduja, Birla, and Raheja, Tata’s strategic investment cements its position in the premium healthcare sector.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

BCL Industries Secure Additional 23,054 KL Ethanol Supply Order

BCL Industries Limited and its subsidiary, Svaksha Distillery Limited have received 23,054 KL of extra ethanol to supply to Oil Marketing Companies (OMCs). It is made from Food Corporation of India (FCI) rice and was allocated through an OMC tender.

Order Value and Distribution

The total order is valued at ₹134.87 crore. BCL Industries will supply 14,302 KL of ethanol worth ₹83.67 crore, while Svaksha Distillery will provide 8,752 KL valued at ₹51.20 crore. This new order is in addition to the previously allocated 182,485 KL.

Government Initiatives and Ethanol Blending Program

The Indian government and OMCs are aggressively promoting ethanol blending in petrol to reduce the country’s carbon footprint and decrease dependency on crude oil imports. Ethanol derived from agricultural sources like FCI rice supports energy security and environmental sustainability. 

Company Overview and Operations

Established in 1976, BCL Industries operates in multiple sectors, including edible oils, rice milling, grain-based distilleries and real estate. The company has manufacturing plants in Punjab and West Bengal. As a major producer of grain-based ethanol in India, BCL Industries plays a significant role in the country’s ethanol supply chain.

Stock Performance

As of February 20, 2025, at 9:35 AM, with a market capitalisation of ₹11.29 billion, the shares of BCL Industries are trading at ₹38.51 per share, reflecting a surge of 5.02% from the previous day’s closing price. Over the past month, the stock has registered a loss of 25.27%. The stock’s 52-week high stands at ₹84.40 per share, while its 52-week low is ₹34.50 per share.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Medicamen Biotech Enters Strategic Manufacturing & Supply Agreement With US Distributor

Medicamen Biotech Limited has announced a significant partnership under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has entered into a long-term Manufacturing & Supply Agreement with a prominent pharmaceutical distributor and marketing entity operating in the United States and Europe. This strategic collaboration aims to enhance Medicamen Biotech’s global presence and leverage its manufacturing capabilities.

Expansion into International Markets

Under the agreement, Medicamen Biotech will manufacture products for the US-based entity according to its technical specifications. The collaboration is expected to last for ten years, ensuring a stable and long-term engagement. The agreement is strictly a manufacturing and supply arrangement with no share exchange involved. Additionally, 25% of the agreement’s total consideration has been received upon signing.

This partnership aligns with Medicamen Biotech’s growth strategy, reinforcing its position in international markets, particularly in the regulated sectors of the US and Europe. The company’s USFDA-approved oncology unit will play a crucial role in executing this agreement, highlighting its commitment to high-quality manufacturing and research-driven process development.

Leveraging Advanced Manufacturing Capabilities

Medicamen Biotech will utilise its advanced manufacturing infrastructure to produce pharmaceutical products tailored to the requirements of its US partner. The agreement underscores the company’s ability to provide value-added custom manufacturing services, further strengthening its foothold in the global pharmaceutical industry. With no related party transactions involved, this deal has been structured at arm’s length, ensuring transparency and compliance with regulatory norms.

Medicamen Biotech Share Performance

As of February 20, 2025, at 11:33 AM, the shares of Medicamen Biotech are trading at ₹518.00 per share, reflecting a surge of 4.27% from the previous day’s closing price.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.